IDNA logo

IDNAiShares Genomics Immunology and Healthcare ETF

$29.14
$0.82
(2.74%)
Today
Closed $29.14
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
Vol39,693.00
52W High$31.41
52W Low$20.15
48

Neutral Sentiment

How do you feel about IDNA?

News
all
press releases
Why Did BNTX Stock Tumble 17% Pre-Market Today?
BioNTech co-founders Ugur Sahin and Özlem Türeci are set to leave the company to head the new venture.
Stocktwits
News Placeholder
More News
News Placeholder
IBRX Stock Reverses Pre-Market Gains After ANKTIVA Combo Shows Stronger Bladder Cancer Responses – Retail Sees Consolidation Before Next Leg Up
The company said it plans to submit a biologics license application by the fourth quarter of 2026.
Stocktwits
News Placeholder
AI Scare Back in the Market: ETFs That Stayed Steady
AI fears rattled markets as IBM sank and tech slid, but ETFs like OIH, BWET, IDNA and HDGE stayed resilient, gaining even as major indexes fell.
Zacks
News Placeholder
Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review
The FDA has now accepted the biologics license application for review, setting a Prescription Drug User Fee Act goal date of Aug. 5, 2026.
Stocktwits
News Placeholder
Why Is ALVO Stock Rising Pre-Market Today?
The company reported that the study showed AVT80, its biosimilar candidate to Entyvio, met all primary endpoints.
Stocktwits
News Placeholder
Here's Why Biotech ETFs Are Rallying Hard
Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.
Zacks
<
...
1
>

Advertisement|Remove ads.